Clinical Trial Update: International Registry on Cardioversion of Atrial Fibrillation (MK-6621-051)

View source ↗

Summary

This international registry study (MK-6621-051) on cardioversion in atrial fibrillation has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• MK-6621-051

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Atrial Fibrillation | Status: COMPLETED | Results posted: 2014-01-30